Form 4: Tenet Healthcare Director J. Robert Kerrey Exercises RSUs and Sells Shares

Tenet Healthcare Corp. Director J. Robert Kerrey reported exercising restricted stock units and subsequently selling a portion of common stock, while also receiving a new grant of restricted stock units.

Summary

• J. Robert Kerrey, a Director of Tenet Healthcare Corp. (THC), reported multiple transactions involving company stock.
• On May 23, 2025, Mr. Kerrey exercised 1,939 restricted stock units (RSUs), converting them into common stock.
• Of these exercised RSUs, 37% were settled for cash and 63% for shares of THC common stock.
• On the same day, May 23, 2025, Mr. Kerrey disposed of 717 shares of THC common stock at a price of $161.33 per share.
• Following these transactions, Mr. Kerrey's direct beneficial ownership of common stock decreased from 24,316 shares to 23,599 shares.
• Additionally, on May 22, 2025, Mr. Kerrey was granted 1,643 new restricted stock units under the Company's Stock Incentive Plan.
• These newly granted RSUs are equivalent to one share of common stock each and are scheduled to vest on May 22, 2026.
• Mr. Kerrey has the option to elect to receive up to 37% of these new RSUs in cash instead of shares upon vesting.

Sentiment

Score: 6

Explanation: The sentiment is neutral to slightly positive. While there's a sale of shares, it's offset by the exercise of RSUs and a new RSU grant, suggesting routine compensation management rather than a negative signal about the company's prospects. The sale is relatively small compared to total holdings.

Positives

• The grant of 1,643 new restricted stock units indicates continued compensation and alignment of the director's interests with the company's performance.

Negatives

• A director selling shares, even if part of a pre-arranged plan or for tax purposes, can sometimes be perceived as a minor negative signal by the market, though this sale is relatively small.

Future Outlook

This Form 4 filing does not contain any forward-looking statements or guidance regarding the company's future outlook.

Industry Context

This document is an insider transaction report (Form 4) for a director of Tenet Healthcare Corp., a company in the healthcare sector. It details personal stock transactions related to compensation and does not provide broader industry context or trends.

Related Party Transactions

• The restricted stock unit grants and exercises are standard compensation-related transactions between the company and its director.

Stakeholder Impact

• Shareholders: The sale of shares by a director could be perceived as a minor negative signal, but the overall context of RSU exercise and new grants suggests routine compensation management, which is unlikely to significantly impact shareholder sentiment.

Next Steps

• The newly granted 1,643 Restricted Stock Units are scheduled to vest on May 22, 2026.

Key Dates

Recommendation

Keywords

Tenet Healthcare, THC, J. Robert Kerrey, Form 4, Insider Trading, Restricted Stock Units, Stock Sale, Director Compensation, SEC Filing, Healthcare